NCT03204123Active, not recruitingPhase 2
PSMA PET Imaging of Recurrent Prostate Cancer
Source: ClinicalTrials.gov · Last updated 26 Aug 2026
Brief summary (registry, in English)
The purpose of this study is to see if a new diagnostic research agent named 68Ga-HBED-CC-PSMA can show prostate cancer on a PET/CT scan that cannot be seen on other standard imaging even when the PSA levels are very low.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 1171 (estimated)
- First submitted
- 27 Jun 2017
- Start date
- 26 Jun 2017
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Diseases
- Prostate cancer
- NCT number
- NCT03204123
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 1171
- From 26 Jun 2017 to the primary completion date, 30 Jun 2027
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient with claustrophobia that would preclude PET/CT or PET/MR imaging or other contraindications to CT imaging.
Who the study is looking for
- Biopsy proven adenocarcinoma of the prostate
- Initially treated with definitive local therapy (surgery and radiation therapy are the most common treatments, but other treatments are also eligible)
- For patients initially treated with surgery, radiation therapy, brachytherapy, or cryotherapy:
- PSA ≥ 0.2 ng/mL in at least two consecutive tests within 6 months of date of consent for patients
- Note: The most recent PSA value must be within 6 weeks of consent
- For patients who have received additional treatment in the recurrent or metastatic setting:
- ° PSA ≥ 2 ng/ml above the most recent therapy nadir
- Age ≥ 18 years
- Patient must be able to tolerate PET/CT or PET/MR imaging
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (Consent Only) Coordinator of this site? Confirm its status | Basking Ridge | United States | Unknown status |
| Memorial Sloan Kettering Commack (Consent only) Coordinator of this site? Confirm its status | Commack | United States | Unknown status |
| Memorial Sloan Kettering Westchester (Consent only) Coordinator of this site? Confirm its status | Harrison | United States | Unknown status |
| Memorial Sloan Kettering Monmouth (Consent Only) Coordinator of this site? Confirm its status | Middletown | United States | Unknown status |
| Memorial Sloan Kettering Bergen (Consent Only) Coordinator of this site? Confirm its status | Montvale | United States | Unknown status |
| Memorial Sloan-Kettering Cancer Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
| Memorial Sloan Kettering Nassau (Consent Only) Coordinator of this site? Confirm its status | Uniondale | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.